Markets & Stocks

Stock quotes, market indicators and the latest market news.

Market Summary Market News Stock Quotes Market Movers

Recent Quotes

View Full List

My Watchlist

Indicators

Local Stocks

Markets:

Overview

News

Currencies

International

Treasuries

Biodexa Pharmaceuticals plc - American Depositary Shares (NQ:BDRX)

0.6049 -0.0277 (-4.38%)

Delayed Quote Updated: 12:56 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biodexa Pharmaceuticals plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Dow Gains 100 Points; McDonald's Shares Rise After Q4 Results ↗

February 10, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 21, 2024

Via Benzinga

Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic

November 21, 2024

Via ACCESSWIRE

BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm

October 28, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Biodexa's MX-110 Continues to Show Promise in Recurrent Glioblastoma (rGBM), the Deadliest Brain Cancer

October 17, 2024

Via ACCESSWIRE

How Is The Market Feeling About Biodexa Pharmaceuticals? ↗

July 16, 2024

Via Benzinga

BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm

October 20, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 17, 2024

Via Benzinga

Why Is Brain Cancer-Focused Biodexa Pharmaceuticals Stock Trading Lower On Thursday? ↗

October 17, 2024

Biodexa Pharmaceuticals reports updates from the MAGIC-1 study on MTX110 for recurrent glioblastoma. MTX110 has also demonstrated potential in treating diffuse midline glioma, a rare brain cancer, with...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 16, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 16, 2024

Via Benzinga

Biodexa Pharmaceuticals Stock Is Soaring After The Close: What's Driving Shares Higher? ↗

October 15, 2024

Biodexa Pharmaceuticals shares are soaring in Tuesday's after-hours session after the company announced it was granted an extension to demonstrate compliance with Nasdaq listing requirements.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 02, 2024

Via Benzinga

Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 12, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 12, 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Via InvestorPlace

Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

July 12, 2024

Via Benzinga

Gold Rises Sharply; Methode Electronics Shares Spike Higher ↗

July 11, 2024

Via Benzinga

Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 11, 2024

Via Benzinga

JOBY Stock Pops After Completing 523-Mile eVTOL Flight ↗

July 11, 2024

Joby Aviation stock is flying higher on Thursday after the eVTOL company reported a new milestone for a hydrogen-electric aircraft.

Via InvestorPlace

Cancer-Focused Nano-Cap Biodexa Pharmaceuticals Stock Is Surging On Thursday - Here's Why ↗

July 11, 2024

Biodexa Pharmaceuticals shares surge following phase 2 trial results for eRapa, a potential treatment for Familial Adenomatous Polyposis. The study showed a 17% median reduction in polyp burden and a...

Via Benzinga

KZIA Stock Alert: Kazia Continues Its Surge on Thursday With 51% Gains ↗

July 11, 2024

Kazia Therapeutics stock is still rallying on Thursday with heavy trading of KZIA alongside its latest positive clinical trial data.

Via InvestorPlace

Why Is Biodexa Pharmaceuticals (BDRX) Up 56% Today? ↗

July 11, 2024

Biodexa Pharmaceuticals stock is up on Thursday with heavy trading of BDRX shares alongside positive clinical trial news.

Via InvestorPlace

Nasdaq Dips Over 300 Points; PepsiCo Reports Weak Sales ↗

July 11, 2024

Via Benzinga

US Stocks Edge Higher; Inflation Slows To 3% In June ↗

July 11, 2024

Via Benzinga

Topics Economy

Biodexa Announces Additional Positive Results Of Phase 2 Trial Of eRapa in Treatment Of Precancerous Polyps in the GI Tract - Now 12-Month Data

July 11, 2024

Via ACCESSWIRE

Promising Phase 2 Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have a 100% Lifetime Risk of Colorectal Cancer

June 03, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 28, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.